CoV Spike E-Mosaic
- Product Code: SARS-014
- Synonyms/Product Alternate Names: Coronavirus 2019 Spike E-Mosaic Recombinant
Please allow 2-3 weeks average availability
A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV or COVID-19 was found in the city of Wuhan, Hubei province of China on December 2019.
The 2019-nCoV (SARS-CoV-2) shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity, thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.
RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
The E. coli derived recombinant protein contains the Coronavirus 2019 spike E-Mosaic immunodominant regions, fused to His tag at C-terminal.
Physical Appearance: Sterile Filtered clear solution.
Formulation:CoV 2019 Spike E-Mosaic Protein 1mg/ml solution is supplied in 1x PBS.
Stability: CoV 2019 Spike E-Mosaic Protein is shipped on ice packs. Upon arrival, Store at -20°C.
- Origin: Escherichia coli
- Storage Conditions: -20 ℃
- Purity: >90% pure as determined SDS-PAGE
Delivery Details: All quantities are subject to availability. Please allow 7-10 days for delivery.